author-photo

Henk Visscher

University of British Columbia

22

Papers

1933

Citations

Citation Trend

Filter By

Papers (19) Sort By

Journal Conference Others

An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines

2018 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (4)
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.

2015 Nature Genetics
Show All
- Source
- Cite
- Save
Citations (146)
Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children.

2015 Pharmacogenomics
Show All
- Source
- Cite
- Save
Citations (61)
Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity.

2014 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (19)
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children

2013 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (109)
Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (276)
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin

2012 Pharmacogenomics Journal
Show All
- Source
- Cite
- Save
Citations (156)
HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia

2011 European Journal of Human Genetics
Show All
- Source
- Cite
- Save
Citations (122)
PHARMACOGENOMICS OF SERIOUS ADVERSE DRUG REACTIONS IN PEDIATRIC ONCOLOGY

2011 Journal de la thérapeutique des populations et de la pharamcologie clinique
Show All
- Source
- Cite
- Save
Citations (23)
Pharmacogenomics of cardiovascular drugs and adverse effects in pediatrics.

2011 Journal of Cardiovascular Pharmacology
Show All
- Source
- Cite
- Save
Citations (15)